RE: Sir Marc Feldman, Hemo Executive Chairman24 Nov 2020 10:47
JHFH - your intentions are good with your commentary, and in an ideal world, yes, that is what Mint would benefit from - ie a rising share price. But - this source of financing has it's risk - if Mint gets impatient, or makes a concerted effort, they can screw the share price and make money off it (at the risk of ruining their own reputation funding startups). The limitation here though I have to agree is the market cap...they can make money pushing the share price down, but the market cap is not enough in my mind relative to the CLN amounts to really make a mint from it....errr. Perhaps with significant leverage their side but it starts to sound like a massive amount of engineering and conspiring upfront - which is completely disingenuous and when there will be plenty more to make with a rising share price if Hemo delivers results.
Unrelated but related - does anyone know the current level of shorts? The SP seems to be being pushed by something.